Chengdu Tianfu Sanjiang Asset Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
3
- Portfolio
-
2
Chengdu Tianfu Sanjiang Asset Management General Information
Company Description
Chengdu Tianfu Sanjiang Asset Management is a venture capital firm based in Chengdu, China.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Chengdu, Sichuan
- China
Chengdu Tianfu Sanjiang Asset Management Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BoomRay Pharmaceuticals | 14-Jul-2022 | Early Stage VC | Biotechnology | Generating Revenue | ||
| OrienSpace | 19-May-2022 | Aerospace and Defense | Generating Revenue | |||
| OrienSpace | 08-Jun-2021 | Aerospace and Defense | Generating Revenue |
Chengdu Tianfu Sanjiang Asset Management Investments by Industry, Year, and Region
Chengdu Tianfu Sanjiang Asset Management Co-Investors (12)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| CMBC Capital | 1 |
|
|
||
| HSG (Hong Kong) |
|
|
|||
| Puhua Capital |
|
|
|||
| Suzhou Oriza Holdings Corporation |
|
|
|||
| Vision Plus Capital |
|
|
Chengdu Tianfu Sanjiang Asset Management FAQs
-
What is Chengdu Tianfu Sanjiang Asset Management?
Chengdu Tianfu Sanjiang Asset Management is a venture capital firm based in Chengdu, China.
-
Where is Chengdu Tianfu Sanjiang Asset Management headquartered?
Chengdu Tianfu Sanjiang Asset Management is headquartered in Chengdu, China.
-
How many investments has Chengdu Tianfu Sanjiang Asset Management made?
Chengdu Tianfu Sanjiang Asset Management has made 3 investments.
-
What has Chengdu Tianfu Sanjiang Asset Management invested in?
Chengdu Tianfu Sanjiang Asset Management has made numerous investments in companies like BoomRay Pharmaceuticals and OrienSpace within the Biotechnology and Aerospace and Defense industries.
-
What has Chengdu Tianfu Sanjiang Asset Management invested in recently?
Chengdu Tianfu Sanjiang Asset Management's latest investment was on 14-Jul-2022 in BoomRay Pharmaceuticals, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process